Safety,Tolerability, and Pharmacokinetic of KPCXM18 for Injection
Clinical trial NCT04629287 · UNKNOWN
Trial details
- NCT number
- NCT04629287
- Sponsor
- Kunming Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2021-12-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.